Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.71 - $2.08 $2,907 - $3,536
-1,700 Reduced 14.53%
10,000 $19,000
Q2 2023

Aug 11, 2023

BUY
$1.56 - $2.38 $18,252 - $27,846
11,700 New
11,700 $22,000
Q1 2022

May 16, 2022

SELL
$3.01 - $4.81 $40,033 - $63,972
-13,300 Reduced 43.89%
17,000 $51,000
Q3 2021

Nov 15, 2021

BUY
$3.3 - $6.49 $51,480 - $101,244
15,600 Added 106.12%
30,300 $168,000
Q4 2020

Feb 16, 2021

SELL
$5.35 - $7.77 $87,205 - $126,651
-16,300 Reduced 52.58%
14,700 $79,000
Q3 2020

Nov 16, 2020

BUY
$7.22 - $9.11 $81,586 - $102,943
11,300 Added 57.36%
31,000 $235,000
Q2 2020

Aug 14, 2020

BUY
$4.93 - $10.26 $97,121 - $202,122
19,700 New
19,700 $171,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $32.1M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.